MSLN and pancreatic neoplasm: One study found that treating pancreatic tumors, characterized by their dense desmoplastic stroma, in mice with FAP-targeting CAR T-cells reduced the integrity of the desmoplastic matrix, thereby making the tumors more susceptible to infiltration by CAR T-cells targeted against mesothelin, a TAA (126).